UnitedHealth Group reported strong first-half results with a 9% revenue growth and an 18% increase in adjusted EPS, exceeding expectations. The raised full-year earnings guidance and positive management outlook on strategic growth initiatives are likely to boost investor confidence in the short term.

[1]